Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy.
Nat Commun
9:
2018
4112
|
57
|
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.
Sci Rep
10:
2020
9778
|
6
|
Chromosomal copy number heterogeneity predicts survival rates across cancers.
Nat Commun
12:
2021
3188
|
70
|
A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer.
Sci Rep
16:
2026
8843
|
0
|